Jump to content
RemedySpot.com

Vertex Reports Second Quarter 2011 Financial Results and Provides Updates on Launch of INCIVEK (telaprevir) and Development Programs

Rate this topic


Guest guest

Recommended Posts

Guest guest

Vertex Reports Second Quarter 2011 Financial Results and Provides Updates on

Launch of INCIVEK (telaprevir) and Development Programs

From the PharmaLive.com News Archive - Jul. 28, 2011

Vertex Pharmaceuticals Incorporated today reported consolidated financial

results for the quarter ended June 30, 2011 and provided an update on the

launch of INCIVEK (telaprevir) tablets and its development programs.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...